Active Pharmaceutical Ingredients (APIs) in Drug Formulation
Discover why APIs are the backbone of every drug formulation. Learn about the critical role of API quality, physical attributes, and how they impact therapeutic success.
R
Rraynex Editorial Team
2 min read
Overview
The active pharmaceutical ingredient is often referred to as the drug substance by those working in the pharmaceutical supply chain. It truly goes far beyond that straightforward label to someone who works as a formulator. It acts as the fundamental building block for the drug's stability, efficacy, and safety.
Excipients aid in a product's delivery process. However, overall therapeutic success is still controlled by the API. Manufacturers who produce FDFs, or finished dosage forms, must understand the subtleties of API quality. This is more than just determining purity levels. It is crucial to creating a product that dominates the market.
The biologically active component of any medication product is known as an active pharmaceutical ingredient. Consider injectables, creams, tablets, and capsules. It creates the health effects that doctors intend.
Consider an Omeprazole capsule. The API is the omeprazole powder found inside. Excipients include the surrounding shell and any additional fillers.
The 70/30 Rule for Quality
The 70/30 rule for quality is used in formulation development. Experts frequently note that approximately 70% of a drug's effectiveness is determined by the physicochemical characteristics of the API. Modifications to excipients and processing procedures account for the remaining 30%.
Why Formulators Need the "Right" API
Finding the cheapest price per kilogram is only one aspect of sourcing an API. It involves determining which grade best suits your formulation approach. The physical attributes of your API are the foundation of your finished product for the following reasons:
1. Particle Size Distribution (PSD)
The particle size of an API directly impacts dissolution rate and bioavailability.
Too coarse: The drug may not dissolve fast enough in the patient's stomach (low bioavailability).
Too fine: The powder may become sticky and difficult to compress into tablets, leading to manufacturing defects like capping or sticking.
2. Polymorphism
Many APIs can exist in different crystalline forms (polymorphs). Different polymorphs can have vastly different solubilities. Using an inconsistent API source can lead to a batch failing dissolution tests because the crystal structure changed.
3. Impurity Profiling
Strict regulatory bodies (like the USFDA and EMA) are increasingly focused on impurity limits. High-quality APIs with low impurity profiles reduce the risk of forming toxic degradation products during the shelf-life of the medicine.
Frequently Asked Questions
What information should an API sourcing enquiry include?
Provide the exact substance, required grade, intended application, quantity, destination market and relevant specification or documentation requirements.
Which documents should a procurement enquiry request?
Ask which specifications, batch Certificates of Analysis, stability information and relevant quality documents are available for the specific product and manufacturing site. Availability should be confirmed directly.
Put insight into practice
Let’s discuss your next formulation project.
Share your product, strength, release requirements, expected quantity and destination market with our team.
A guide to pharmaceutical pellets for formulators. Learn about pelletisation, release designations and what to confirm when evaluating a pellet specification.
Discover why GMP compliance is crucial for pharmaceutical manufacturing. Learn how it ensures consistency, prevents contamination, and builds trust in the supply chain.